307 related articles for article (PubMed ID: 20093590)
1. MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization.
Iyer VR; Lee SI
AJR Am J Roentgenol; 2010 Feb; 194(2):311-21. PubMed ID: 20093590
[TBL] [Abstract][Full Text] [Related]
2. Indirect comparison of the diagnostic performance of
Hu X; Li D; Liang Z; Liao Y; Yang L; Wang R; Wang P; Cai J
BMC Cancer; 2021 Oct; 21(1):1080. PubMed ID: 34615498
[TBL] [Abstract][Full Text] [Related]
3. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
4. Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography.
Grab D; Flock F; Stöhr I; Nüssle K; Rieber A; Fenchel S; Brambs HJ; Reske SN; Kreienberg R
Gynecol Oncol; 2000 Jun; 77(3):454-9. PubMed ID: 10831359
[TBL] [Abstract][Full Text] [Related]
5. Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings.
Fenchel S; Grab D; Nuessle K; Kotzerke J; Rieber A; Kreienberg R; Brambs HJ; Reske SN
Radiology; 2002 Jun; 223(3):780-8. PubMed ID: 12034950
[TBL] [Abstract][Full Text] [Related]
6. Characterization of tubo-ovarian abscess mimicking adnexal masses: Comparison between contrast-enhanced CT,
Fan H; Wang TT; Ren G; Fu HL; Wu XR; Chu CT; Li WH
Taiwan J Obstet Gynecol; 2018 Feb; 57(1):40-46. PubMed ID: 29458901
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI.
Nam EJ; Yun MJ; Oh YT; Kim JW; Kim JH; Kim S; Jung YW; Kim SW; Kim YT
Gynecol Oncol; 2010 Mar; 116(3):389-94. PubMed ID: 19926121
[TBL] [Abstract][Full Text] [Related]
8. Role of PET/CT in ovarian cancer.
Prakash P; Cronin CG; Blake MA
AJR Am J Roentgenol; 2010 Jun; 194(6):W464-70. PubMed ID: 20489063
[TBL] [Abstract][Full Text] [Related]
9. [Preoperative assessment of asymptomatic adnexal tumors by positron emission tomography and F 18 fluorodeoxyglucose].
Fenchel S; Kotzerke J; Stöhr I; Grab D; Nüssle K; Rieber A; Kreienberg R; Brambs HJ; Reske SN
Nuklearmedizin; 1999; 38(4):101-7. PubMed ID: 10392374
[TBL] [Abstract][Full Text] [Related]
10. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
11. Pelvic MRI as the "gold standard" in the subsequent evaluation of ultrasound-indeterminate adnexal lesions: a systematic review.
Anthoulakis C; Nikoloudis N
Gynecol Oncol; 2014 Mar; 132(3):661-8. PubMed ID: 24183731
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S
Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET/CT as a molecular biomarker in ovarian cancer.
Nowosinska E; Avril S; Murray I; Szyszko T; Avril N
Cancer Biomark; 2010-2011; 8(4-5):167-75. PubMed ID: 22045351
[TBL] [Abstract][Full Text] [Related]
14. Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment.
Picchio M; Sironi S; Messa C; Mangili G; Landoni C; Gianolli L; Zangheri B; Viganò R; Aletti G; De Marzi P; De Cobelli F; Del Maschio A; Ferrari A; Fazio F
Q J Nucl Med; 2003 Jun; 47(2):77-84. PubMed ID: 12865867
[TBL] [Abstract][Full Text] [Related]
15. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
Kim CK; Park BK; Choi JY; Kim BG; Han H
J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose.
Torizuka T; Nobezawa S; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Takekuma M; Maeda M; Ouchi Y
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):797-803. PubMed ID: 12029554
[TBL] [Abstract][Full Text] [Related]
18. [MRI and CT-scan in presumed benign ovarian tumors].
Thomassin-Naggara I; Bazot M
J Gynecol Obstet Biol Reprod (Paris); 2013 Dec; 42(8):744-51. PubMed ID: 24210236
[TBL] [Abstract][Full Text] [Related]
19. Adnexal masses: accuracy of detection and differentiation with multidetector computed tomography.
Tsili AC; Tsampoulas C; Charisiadi A; Kalef-Ezra J; Dousias V; Paraskevaidis E; Efremidis SC
Gynecol Oncol; 2008 Jul; 110(1):22-31. PubMed ID: 18486202
[TBL] [Abstract][Full Text] [Related]
20. [MR imaging of the pelvis in characterization of adnexal masses].
Hauth EA; Wolfgarten B; Kimmig R; Forsting M
Zentralbl Gynakol; 2005 Dec; 127(6):373-9. PubMed ID: 16341980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
